Clinical trial
Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell…
NCT00203931 · University of Chicago, Other · Terminated
Key facts
| NCT number | NCT00203931 |
|---|---|
| Title | Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer |
| Official title | A Randomized Phase II Trial Comparing Cetuximab With Concurrent Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer Refractory to Primary Treatment |
| Lead sponsor | University of Chicago, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Cetuximab, Pemetrexed |
| Enrollment | 55 |
| Start date | Mar 1, 2005 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2009 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 31, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: